Friday, October 19, 2018 11:11:42 AM
"Remarkably, when the PLX-RAD cells were injected IM in the same manner in naïve non-irradiated mice, only negligible levels of the PLX-RAD secreted human proteins were detected in the plasma (with very limited short-term elevations of IL-6, MCP-1 and Fractalkine). This suggests that the systemic stress signals related to ARS stimulate the IM injected PLX-RAD cells in the acute phase in which they were needed to trigger the controlled transient co-secretion of these proteins to the circulation in a manner in the acute phase in which they were most needed." (Figure 3B–J).
The data on the pro-regenerative secretome of the PLX-RAD cells in response to stress may have implications for other wide range of regenerative therapies. Muscle regeneration by stem/progenitor cell recruitment, proliferation and survival are supported by the inflammatory cells which are affected by the PLX-RAD cell secretome in response to ARS.
We can hypothesize that the mechanism of PLX-RAD effects may be related to their possible physiological role in the placenta, where they respond to messages carried by the embryo circulation, potentially serving as both sensors and responders to its stress signals and as secretors of pro-regenerative proteins. In the current study which is focused on short-term follow-up of acute effects of less than 8 Gy irradiation, no muscle damage was expected. But in other degenerative processes, the haematopoietic system is recruited by the PLX-RAD secretome, boosting different haematopoietic lineages including eosinophils, macrophages and T cells. In such circumstances, the induced secretome of potent PLX-RAD cells may participate in the regeneration of tissues such as damaged muscles,86-88 an issue which deserves further investigation.
In summary, we provide detailed mechanistic insights into simple well-regulated allogeneic/xenogeneic PLX-RAD cell-based treatments. The mode of action of these cells in mitigation of ARS following high dose irradiation is based on the induction of a faster regeneration of highly damaged or depleted BM, thus reversing subsequent life-threatening pancytopenia and severe weight loss.
https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.12342
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM